Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Wave Life Sciences Ltd (NASDAQ: WVE) was $6.03 for the day, down -9.19% from the previous closing price of $6.64. In other words, the price has decreased by -$9.19 from its previous closing price. On the day, 2.42 million shares were traded. WVE stock price reached its highest trading level at $6.76 during the session, while it also had its lowest trading level at $5.845.
Ratios:
Our analysis of WVE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.89 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on February 25, 2025, initiated with a Buy rating and assigned the stock a target price of $26.
On October 16, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $22.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 20 ’25 when HENRY CHRISTIAN O sold 10,500 shares for $9.77 per share. The transaction valued at 102,574 led to the insider holds 16,115 shares of the business.
Christian Henry bought 10,500 shares of WVE for $102,579 on Mar 20 ’25. On Mar 07 ’25, another insider, BOLNO PAUL, who serves as the President and CEO of the company, sold 169,025 shares for $9.57 each. As a result, the insider received 1,617,569 and left with 338,351 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 925520640 and an Enterprise Value of 656720704. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.55 while its Price-to-Book (P/B) ratio in mrq is 4.40. Its current Enterprise Value per Revenue stands at 6.064 whereas that against EBITDA is -6.166.
Stock Price History:
The Beta on a monthly basis for WVE is -0.84, which has changed by 0.03965521 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, WVE has reached a high of $16.74, while it has fallen to a 52-week low of $4.25. The 50-Day Moving Average of the stock is -41.60%, while the 200-Day Moving Average is calculated to be -38.51%.
Shares Statistics:
WVE traded an average of 1.10M shares per day over the past three months and 1962190 shares per day over the past ten days. A total of 153.04M shares are outstanding, with a floating share count of 122.54M. Insiders hold about 20.16% of the company’s shares, while institutions hold 79.53% stake in the company. Shares short for WVE as of 1741910400 were 8341644 with a Short Ratio of 7.61, compared to 1739491200 on 9543400. Therefore, it implies a Short% of Shares Outstanding of 8341644 and a Short% of Float of 9.32.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
